2d
MedPage Today on MSNBroadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
1don MSN
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...
HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...
Doctors, clinical officers, nurses, laboratory technologists, pharmacists, community health workers and staff funded by the US Government have been impacted. Service Disruptions: Some facilities ...
A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...
2024 — Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week ... Targeted Immune Intervention and Stopping ART in Model of ...
Opinion
1dOpinion
Monitor on MSNAid freeze hampering efforts to achieve zero discrimination for HIV patientsMany healthcare and social services depend on international aid. Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and severe ...
Still, almost despite itself, it points to true art. By Jason Farago and George Etheredge for The New York Times As a sprawling new exhibit opens in two museums in Amsterdam, the German artist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results